Antimicrobial Agents Practice Questions

Q: All of the following antibacterial agents act by inhibiting cell wall synthesis, except?

Nitrofurantoin. The correct answer is **D. Nitrofurantoin**. **1. Why Nitrofurantoin is the correct answer:** Nitrofurantoin does not inhibit cell wall synthesis. Instead, it is a **prodrug** that is reduced by bacterial flavoproteins (nitroreductases) into highly reactive electrophilic intermediates. These intermediates attack bacterial ribosomal proteins, DNA, RNA, and metabolic enzymes. This multi-targeted mechanism makes it **bactericidal**, particularly in the urinary tract where it reaches high concentrations. **2. Why the other options are incorrect:** * **Carbapenems (e.g., Imipenem, Meropenem):** These are beta-lactam antibiotics that bind to Penicillin-Binding Proteins (PBPs), thereby inhibiting the transpeptidation step of peptidoglycan synthesis in the cell wall [1], [4]. * **Monobactams (e.g., Aztreonam):** These are monocyclic beta-lactams that specifically bind to PBP-3 in aerobic Gram-negative bacteria, leading to cell wall inhibition and lysis. * **Cephamycins (e.g., Cefoxitin, Cefotetan):** These are closely related to 2nd-generation cephalosporins [2]. Like all cephalosporins, they inhibit cell wall synthesis by binding to and inhibiting cell wall transpeptidases [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Nitrofurantoin** is the first-line drug for **uncomplicated Cystitis** (especially in pregnancy), but it is ineffective in Pyelonephritis due to poor tissue penetration. * **Side Effects:** A classic "high-yield" side effect of Nitrofurantoin is **Pulmonary Fibrosis** (with chronic use) and hemolytic anemia in patients with **G6PD deficiency**. * **Cell Wall Inhibitors Mnemonic:** Remember **"V-C-P-B"** (Vancomycin, Cephalosporins, Penicillins, Bacitracin) and their derivatives like Carbapenems and Monobactams [3].

Q: What is the recommended route of administration for vancomycin in pseudomembranous colitis?

Oral. **Explanation:** **1. Why Oral is the Correct Choice:** Pseudomembranous colitis is caused by *Clostridioides difficile* toxin, which affects the colonic mucosa. Vancomycin is a large glycopeptide molecule that is **not absorbed from the gastrointestinal tract** when taken orally. This lack of absorption is therapeutically advantageous in this specific condition because the drug remains concentrated within the intestinal lumen, directly targeting the bacteria at the site of infection. **2. Why Other Options are Incorrect:** * **Intravenous (C):** While IV vancomycin is the standard for systemic infections (like MRSA or endocarditis), it is **ineffective** for pseudomembranous colitis. The drug does not cross the intestinal barrier from the blood into the lumen in sufficient concentrations to kill *C. difficile*. * **Intramuscular (A):** Vancomycin is highly irritating to tissues and can cause local necrosis and severe pain; therefore, IM administration is contraindicated. * **Subcutaneous (D):** Similar to the IM route, subcutaneous injection would cause tissue irritation and lacks the systemic or localized delivery required for this condition. **3. High-Yield NEET-PG Pearls:** * **First-line Treatment:** While oral Vancomycin is a classic answer, current guidelines often list **Fidaxomicin** (oral) as a preferred first-line agent due to lower recurrence rates. * **Red Man Syndrome:** A common side effect associated with **rapid IV infusion** of vancomycin (due to histamine release), not oral administration. * **Metronidazole:** Previously the first-line for mild cases, it is now typically reserved for situations where vancomycin or fidaxomicin are unavailable. * **Mechanism of Action:** Vancomycin inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan chains.

Q: Which orally administered drug is used for treating kala-azar?

Miltefosine. **Explanation:** **Miltefosine** is the correct answer because it is currently the **only orally administered drug** approved for the treatment of Visceral Leishmaniasis (Kala-azar). Originally developed as an anticancer agent, it acts by inhibiting phospholipid metabolism and signal transduction in the *Leishmania* parasite cell membrane. Its oral bioavailability makes it a landmark treatment, especially in resource-limited settings where parenteral administration is challenging. **Analysis of Incorrect Options:** * **Paromomycin (Option A):** This is an aminoglycoside antibiotic. While effective against Kala-azar, it is administered via **intramuscular (IM) injection**. It works by inhibiting protein synthesis. * **Amphotericin B (Option C):** This is the **drug of choice** for Kala-azar due to high efficacy and low resistance. However, it must be administered via **slow intravenous (IV) infusion** (especially the Liposomal form, AmBisome). * **Sodium Stibogluconate (Option D):** This is a pentavalent antimonial. It was historically the first-line treatment but is now limited by high resistance (especially in Bihar, India) and significant toxicity. It is administered via **IV or IM routes**, not orally. **High-Yield Clinical Pearls for NEET-PG:** * **Miltefosine Side Effects:** It is highly **teratogenic** (Category X); effective contraception is mandatory for women of childbearing age during and for 3 months after treatment. It also commonly causes GI upset (vomiting/diarrhea). * **Drug of Choice:** Liposomal Amphotericin B is the preferred treatment in India due to its high cure rate with a single dose. * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** Miltefosine is also used in the management of PKDL, typically requiring a longer duration of treatment (12 weeks).

Q: Which of the following is most active against both dormant and non-dormant bacilli?

Rifampicin. ### Explanation The effectiveness of Anti-Tubercular Drugs (ATD) depends on their ability to act on different subpopulations of *Mycobacterium tuberculosis* based on their metabolic activity and location. **Why Rifampicin is correct:** Rifampicin is a bactericidal drug that inhibits DNA-dependent RNA polymerase. It is unique because it is highly effective against **all populations** of bacilli, including: 1. **Rapidly multiplying bacilli** (extracellular). 2. **Slowly multiplying/Dormant bacilli** (intracellular or within solid necrotic lesions). Because it can kill "persisters" (dormant bacilli) that undergo only occasional spurts of metabolic activity, Rifampicin is considered the most important **sterilizing agent** in TB therapy. **Why the other options are incorrect:** * **Pyrazinamide (A):** It is specifically active against bacilli in an **acidic medium** (intracellularly within macrophages). While it is a potent sterilizing agent, its activity is limited to these specific conditions. * **Streptomycin (C):** It is an aminoglycoside that acts only on **extracellular, rapidly multiplying** bacilli. It cannot penetrate cells effectively and is inactive against dormant or intracellular organisms. * **Isoniazid (D):** It is the most potent **bactericidal** drug against rapidly dividing bacilli. However, it has very little activity against dormant or slow-growing organisms. **NEET-PG High-Yield Pearls:** * **Best Sterilizing Action:** Rifampicin > Pyrazinamide. * **Best Bactericidal Action:** Isoniazid (INH). * **Drug for Prophylaxis:** Isoniazid is the drug of choice for latent TB/chemoprophylaxis. * **Mitchison’s Hypothesis:** Divides bacilli into four types; Rifampicin is the only drug active against all four (Rapidly growing, slow-growing, spurters, and dormant).

Q: All of the following drugs are used in the management of MDR-TB under RNTCP except?

PAS. **Explanation:** The management of **MDR-TB (Multidrug-Resistant Tuberculosis)**—defined as resistance to at least Isoniazid and Rifampicin—has evolved significantly under the National TB Elimination Program (NTEP, formerly RNTCP). **Why PAS is the correct answer:** While **Para-aminosalicylic acid (PAS)** is an effective second-line anti-TB drug, it is currently classified by the WHO and NTEP as a **Group C** drug (Add-on agents). In the standard **Shorter MDR-TB Regimen** (9–11 months) and the **All-Oral Longer Regimen** (18–20 months), PAS is generally reserved as a drug of last resort when a core regimen cannot be constructed using more effective or less toxic drugs. In the context of standard RNTCP/NTEP protocols for MDR-TB, the other options are prioritized higher in the hierarchy. **Analysis of Incorrect Options:** * **Levofloxacin (Option A):** Fluoroquinolones (Levofloxacin or Moxifloxacin) are the **backbone** of MDR-TB treatment (Group A drugs). They are mandatory unless there is documented resistance. * **Ethionamide (Option C):** This is a key component of the **Shorter MDR-TB Regimen** used in India, acting as a core second-line agent. * **Cycloserine (Option D):** Classified as a Group B drug, it is a preferred second-line agent included in most MDR-TB regimens due to its efficacy and lack of cross-resistance with other drugs. **High-Yield Clinical Pearls for NEET-PG:** * **MDR-TB Definition:** Resistance to Isoniazid (H) and Rifampicin (R). * **XDR-TB Definition:** MDR-TB plus resistance to any Fluoroquinolone AND at least one of the Group A drugs (Bedaquiline or Linezolid). * **Bedaquiline:** Inhibits mycobacterial **ATP synthase**; it is now a cornerstone of all-oral MDR-TB regimens. * **Drug of Choice for MDR-TB:** Fluoroquinolones (specifically Levofloxacin/Moxifloxacin) are considered the most important component.

Q: Metronidazole is LEAST likely to be effective in the treatment of which of the following conditions?

Pneumocystosis. **Explanation:** **Metronidazole** is a nitroimidazole derivative that acts by forming reactive cytotoxic intermediates (free radicals) that damage DNA. This process requires a strongly reducing environment, which is only present in **obligate anaerobes** and certain **protozoa**. **Why Pneumocystosis is the correct answer:** * **Pneumocystosis** is caused by *Pneumocystis jirovecii*, which is taxonomically classified as a **fungus**. * Metronidazole has no activity against fungi or aerobic organisms. * The treatment of choice for Pneumocystosis is **Trimethoprim-Sulfamethoxazole (TMP-SMX)**. **Analysis of Incorrect Options:** * **Hepatic amoebiasis:** Metronidazole is the drug of choice for invasive amoebiasis (both intestinal and extra-intestinal/hepatic) caused by *Entamoeba histolytica*. * **Bacteroides fragilis:** This is a gram-negative obligate anaerobe. Metronidazole is highly effective against most anaerobic bacteria below the diaphragm. * **Pseudomembranous colitis:** Caused by *Clostridioides difficile*. While oral Vancomycin or Fidaxomicin are now preferred first-line agents, Metronidazole remains an effective alternative, especially in mild cases or resource-limited settings. **NEET-PG High-Yield Pearls:** * **Spectrum:** "Below the diaphragm" anaerobes (*B. fragilis*), *Trichomonas vaginalis*, *Giardia*, and *E. histolytica*. * **Side Effects:** Metallic taste, **Disulfiram-like reaction** with alcohol, and peripheral neuropathy (with long-term use). * **Drug of Choice for:** Bacterial vaginosis, Trichomoniasis, and Giardiasis. * **Mnemonic for Metronidazole uses (GET GAP):** **G**iardiasis, **E**ntamoeba, **T**richomoniasis, **G**ardnerella vaginalis, **A**naerobes (*B. fragilis*), **P**ylori (*H. pylori*).

Q: Streptococcus pyogenes has not shown resistance to which of the following antimicrobial agents?

Penicillin. **Explanation:** The correct answer is **Penicillin**. Despite decades of clinical use, *Streptococcus pyogenes* (Group A Streptococcus) remains **100% susceptible** to Penicillin. No clinical isolate has ever demonstrated documented resistance to beta-lactams in this species. **Why Penicillin is Correct:** The primary mechanism of action for Penicillin involves binding to **Penicillin-Binding Proteins (PBPs)** to inhibit cell wall synthesis. In *S. pyogenes*, the PBPs have remained highly conserved, meaning the binding affinity for Penicillin has not changed. Therefore, Penicillin G or V remains the drug of choice for treating streptococcal pharyngitis and necrotizing fasciitis. **Why Other Options are Incorrect:** * **Erythromycin (Macrolides):** Resistance is well-documented and increasing (often 5–15% globally). It occurs via *erm* genes (ribosomal methylation) or *mef* genes (efflux pumps). * **Tetracycline:** High levels of resistance exist worldwide due to the acquisition of *tet* genes, which mediate ribosomal protection or efflux. * **Cotrimoxazole:** *S. pyogenes* can utilize exogenous folates to bypass the metabolic blockade created by sulfonamides and trimethoprim, leading to inherent and acquired resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Penicillin is the gold standard for *S. pyogenes*. If the patient is allergic, Macrolides (Erythromycin/Azithromycin) or Clindamycin are used, but susceptibility testing is required. * **Eagle Effect:** In severe infections (Toxic Shock Syndrome), Penicillin may be less effective due to the "stationary phase" of bacteria. In such cases, **Clindamycin** is added because it inhibits toxin production. * **Universal Susceptibility:** Along with *S. pyogenes*, *Treponema pallidum* (Syphilis) also remains universally sensitive to Penicillin.

Q: An 18-year-old college student shares a dorm room with three roommates. One roommate is diagnosed with meningococcal meningitis caused by Neisseria meningitidis. The other three roommates, who were not vaccinated, are given prophylactic antibiotic treatment. This antibiotic is known to cause reddish discoloration of urine or tears. What is the mechanism by which this antibiotic kills bacteria?

Inhibition of RNA synthesis.. **Explanation:** The clinical scenario describes the use of **Rifampicin**, which is the drug of choice for the chemoprophylaxis of meningococcal meningitis in close contacts (like roommates). A classic, high-yield side effect of Rifampicin is the harmless **orange-red discoloration** of body fluids, including urine, sweat, and tears. **1. Why the Correct Answer is Right:** Rifampicin exerts its bactericidal effect by **inhibiting RNA synthesis**. Specifically, it binds to the **beta-subunit of DNA-dependent RNA polymerase**, thereby preventing the initiation of transcription (mRNA synthesis). Since the bacteria cannot produce essential proteins without mRNA, they die. **2. Why Incorrect Options are Wrong:** * **Option A (DNA synthesis):** This is the mechanism of **Fluoroquinolones** (e.g., Ciprofloxacin), which inhibit DNA Gyrase and Topoisomerase IV. While Ciprofloxacin can be used for prophylaxis, it does not cause red discoloration of urine. * **Option C (Protein synthesis):** This is the mechanism of Aminoglycosides, Tetracyclines, and Macrolides. These drugs act on the 30S or 50S ribosomal subunits, not the RNA polymerase enzyme. * **Option D (Membrane permeability):** This is the mechanism of **Polymyxins** (e.g., Polymyxin B, Colistin) or Daptomycin, which act like detergents to disrupt the bacterial cell membrane. **Clinical Pearls for NEET-PG:** * **Meningococcal Prophylaxis:** Rifampicin (Drug of Choice), Ciprofloxacin (Single dose), or Ceftriaxone (Safe in pregnancy). * **Rifampicin Resistance:** Occurs due to a mutation in the *rpoB* gene (encoding the beta-subunit of RNA polymerase). * **Enzyme Induction:** Rifampicin is a potent **Cytochrome P450 inducer**, leading to significant drug interactions (e.g., decreasing the efficacy of OCPs and Warfarin).

Q: A client recently diagnosed with HIV is started on highly active antiretroviral therapy. After the first week of therapy, the patient complains of headache, dizziness, and nightmares. Which one of the following antiretroviral drugs is most likely associated with these symptoms?

Efavirenz.. The patient is experiencing classic **Central Nervous System (CNS) side effects** associated with **Efavirenz**, a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). [2] **1. Why Efavirenz is correct:** Efavirenz is notorious for causing neuropsychiatric adverse effects in up to 50% of patients during the first few weeks of therapy. [1] These include dizziness, headache, insomnia, vivid dreams/nightmares, and "foggy" thinking. [1] These symptoms occur because the drug crosses the blood-brain barrier effectively. Patients are often advised to take the medication at bedtime on an empty stomach to minimize the peak plasma concentration and reduce the intensity of these symptoms. **2. Why the other options are incorrect:** * **Lamivudine (NRTI):** Generally well-tolerated. [3] Its primary (though rare) concerns are peripheral neuropathy and pancreatitis, not acute CNS disturbances. * **Tenofovir (NRTI):** Most commonly associated with renal toxicity (Fanconi syndrome) and a decrease in bone mineral density. * **Saquinavir (Protease Inhibitor):** Primarily causes gastrointestinal distress (nausea, diarrhea) and metabolic complications like lipodystrophy, hyperglycemia, and hyperlipidemia. **3. NEET-PG High-Yield Pearls:** * **Teratogenicity:** Efavirenz is generally avoided in the first trimester of pregnancy due to a potential risk of neural tube defects (though recent data has softened this stance, it remains a classic exam fact). [2] * **Contraindication:** It should be avoided in patients with a history of severe psychiatric illness or depression. * **False Positive:** Efavirenz can cause a false-positive screening test for cannabinoids (marijuana). * **Metabolism:** It is both an inducer and an inhibitor of CYP3A4 enzymes. [2]

Q: Which group of antibiotics possesses additional anti-inflammatory and immunomodulatory activities?

Macrolides. **Explanation:** **1. Why Macrolides are correct:** Macrolides (e.g., Erythromycin, Azithromycin, Clarithromycin) are unique because they possess significant **anti-inflammatory and immunomodulatory properties** independent of their antibacterial action. They inhibit the production of pro-inflammatory cytokines (IL-1, IL-6, TNF-α), reduce neutrophil chemotaxis, and decrease mucus hypersecretion. This makes them highly effective in chronic inflammatory airway diseases like **Diffuse Panbronchiolitis (DPB)** and Cystic Fibrosis. **2. Why other options are incorrect:** * **Tetracyclines:** While they have some anti-collagenase activity (useful in rosacea or periodontitis), they are not primarily classified by their systemic immunomodulatory effects in the same clinical context as macrolides. * **Polypeptide antibiotics:** (e.g., Polymyxin B, Bacitracin) These act primarily by disrupting bacterial cell membranes. They are often nephrotoxic and do not exhibit therapeutic anti-inflammatory benefits. * **Fluoroquinolones:** These act by inhibiting DNA Gyrase and Topoisomerase IV. While some studies suggest minor immune modulation, it is not a clinically utilized or defining feature of this class. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Azithromycin is often used in **COPD exacerbations** and **Cystic Fibrosis** specifically for its anti-inflammatory effect to reduce the frequency of exacerbations. * **Motilin Agonism:** Erythromycin acts as a motilin receptor agonist, making it useful as a **prokinetic agent** in diabetic gastroparesis. * **Enzyme Inhibition:** Most macrolides (except Azithromycin) are potent **CYP3A4 inhibitors**, leading to significant drug interactions with Statins, Warfarin, and Theophylline. * **Side Effects:** Remember the mnemonic **MACRO**: **M**otility (GI upset), **A**rrhythmia (QT prolongation), **C**holestatic hepatitis, **R**ash, **E**osinophilia.

Question 1

All of the following antibacterial agents act by inhibiting cell wall synthesis, except?

Accepted Answer

Nitrofurantoin

Answer

Carbapenems

Answer

Monobactams

Answer

Cephamycins

Question 2

What is the recommended route of administration for vancomycin in pseudomembranous colitis?

Accepted Answer

Oral

Answer

Intramuscular

Answer

Intravenous

Answer

Subcutaneous

Question 3

Which orally administered drug is used for treating kala-azar?

Accepted Answer

Miltefosine

Answer

Paromomycin

Answer

Amphotericin

Answer

Sodium stibogluconate

Question 4

Which of the following is most active against both dormant and non-dormant bacilli?

Accepted Answer

Rifampicin

Answer

Pyrazinamide

Answer

Streptomycin

Answer

Isoniazid

Question 5

All of the following drugs are used in the management of MDR-TB under RNTCP except?

Accepted Answer

PAS

Answer

Levofloxacin

Answer

Ethionamide

Answer

Cycloserine

Question 6

Metronidazole is LEAST likely to be effective in the treatment of which of the following conditions?

Accepted Answer

Pneumocystosis

Answer

Hepatic amoebiasis

Answer

Infection caused by Bacteroides fragilis

Answer

Pseudomembranous colitis

Question 7

Streptococcus pyogenes has not shown resistance to which of the following antimicrobial agents?

Accepted Answer

Penicillin

Answer

Erythromycin

Answer

Tetracycline

Answer

Cotrimoxazole

Question 8

An 18-year-old college student shares a dorm room with three roommates. One roommate is diagnosed with meningococcal meningitis caused by Neisseria meningitidis. The other three roommates, who were not vaccinated, are given prophylactic antibiotic treatment. This antibiotic is known to cause reddish discoloration of urine or tears. What is the mechanism by which this antibiotic kills bacteria?

Accepted Answer

Inhibition of RNA synthesis.

Answer

Inhibition of DNA synthesis.

Answer

Inhibition of protein synthesis.

Answer

Increased permeability of the bacterial membrane.

Question 9

A client recently diagnosed with HIV is started on highly active antiretroviral therapy. After the first week of therapy, the patient complains of headache, dizziness, and nightmares. Which one of the following antiretroviral drugs is most likely associated with these symptoms?

Accepted Answer

Efavirenz.

Answer

Lamivudine.

Answer

Tenofovir.

Answer

Saquinavir.

Question 10

Which group of antibiotics possesses additional anti-inflammatory and immunomodulatory activities?

Accepted Answer

Macrolides

Answer

Tetracyclines

Answer

Polypeptide antibiotics

Answer

Fluoroquinolones

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?